Long-term safety and efficacy of ziv-aflibercept in retinal diseases.

Published in: The British journal of ophthalmology (2017)

Repeated intravitreal injections of ziv-aflibercept appear tolerable, safe and efficacious in the therapy of retinal disease.

Keyphrases